News
The litigation extends back to 2018, when ViiV – a joint venture majority owned by GlaxoSmithKline alongside Pfizer and Shionogi – accused Gilead of infringing its patents on HIV integrase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback